COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

NIH Launches Neurological Drug Development Projects

You are viewing archived Blueprint content that is no longer current but is available for reference and record keeping purposes.

Wednesday, July 31, 2013

The National Institutes of Health has launched three innovative projects that will focus on development of therapeutics for Fragile X syndrome, nicotine addiction, and age-related macular degeneration (AMD). These projects are funded through the NIH Blueprint Neurotherapeutics Network which provides access to a variety of drug development resources.

View the full article.